8 results
8-K
EX-3.1
BGNE
BeiGene Ltd
15 Jun 23
BeiGene Highlights Promising Data from Blood Cancer Portfolio and Pipeline at the European Hematology Association Hybrid Congress
4:43pm
8-K
EX-3.1
BGNE
BeiGene Ltd
17 Dec 21
BeiGene Announces Closing of Its RMB22.2 Billion (US$3.5 Billion) Initial Public Offering on the STAR Market of the Shanghai Stock Exchange in China
4:47pm
8-K
EX-3.1
BGNE
BeiGene Ltd
17 Jun 21
BeiGene Announces First Patient Dosed in Global Phase 3 Trial of Anti-TIGIT Antibody Ociperlimab in Non-Small Cell Lung Cancer
4:33pm
8-K
EX-3.1
BGNE
BeiGene Ltd
12 Dec 18
Material Modifications to Rights of Security Holders
12:00am
8-K
EX-3.1
BGNE
BeiGene Ltd
11 Feb 16
Entry into a Material Definitive Agreement
12:00am
S-1
EX-3.1
8aoc8
16 Oct 15
IPO registration
12:00am
DRS
EX-3.1
whlc3g bq
28 Aug 15
Draft registration statement
12:00am
- Prev
- 1
- Next